Request Deal Involvement

Paratek Pharmaceuticals completed the merger with Optinose in a $330m deal.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Hogan Lovells

legal advisors

Hogan Lovells

Evercore

financial advisors

Evercore

Fried Frank Harris Shriver & Jacobson

legal advisors to financial advisors

Fried Frank Harris Shriver & Jacobson

Skadden Arps Slate Meagher & Flom

legal advisors

Skadden Arps Slate Meagher & Flom

Lazard

financial advisors

Lazard

Oaktree Capital Management

debt providers

Oaktree Capital Management

ScientPR

pr advisors

ScientPR

or

Principals

OPTINOSE INC

target

OPTINOSE INC

PARATEK PHARMACEUTICALS

bidder

PARATEK PHARMACEUTICALS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite